LON:VLG

Venture Life Group Interim Earnings Results & Report

Venture Life Group logo
GBX 69.14 +0.14 (+0.20%)
As of 12:37 PM Eastern

Venture Life Group reported Interim earnings on September 30, 2025. The company reported EPS of GBX 0.83.

Earnings Announcement Details

Quarter
Interim
Time
Before Market Opens

Venture Life Group EPS Results

Actual EPS
GBX 0.83
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Venture Life Group Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Conference Call Resources

Venture Life Group Interim Earnings FAQ

Venture Life Group (LON:VLG) reported earnings of GBX 0.83 per share for Interim. The report was announced on Tuesday, September 30, 2025.

Venture Life Group Earnings Headlines

Venture Life tightens share count with latest buyback
FDA clears next-gen therapy with 10 to 40 times greater potency
Time-lapse footage from a recent clinical study shows Natural Killer cells attacking and eliminating cancer cells - and early human data revealed up to a 63.7 percent reduction in cancer burden. One NASDAQ-listed biotech's TriKE platform is designed to keep these immune cells locked onto tumors longer. Its next-generation version, showing potential for 10 to 40 times greater potency, has just cleared an important FDA milestone.tc pixel
See More Venture Life Group Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Venture Life Group? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Venture Life Group and other key companies, straight to your email.

About Venture Life Group

Venture Life is an international consumer self-care company focused on developing and commercialising products for the global self-care market helping our consumers live a longer healthier and more rewarding life. Headquartered in the UK, the Group's product portfolio includes Balance Activ in the area of women's intimate healthcare, Earol® supporting ENT care, Lift and Glucogel product ranges for energy and glucose management and hypoglycaemia, plus the Health & Her product range supporting the hormonal lifecycle. The products, which are typically recommended by pharmacists or healthcare practitioners, are available primarily through health & beauty stores, pharmacies, grocery multiples and e-commerce channels and are sold globally. In the UK, Ireland and the USA these are supplied direct by the company to retailers, elsewhere they are supplied by the Group's international distribution partners.

View Venture Life Group Profile